“Repealing the device tax has strong bipartisan support and is the first step to corporate tax reform. Medical technology companies across the country are struggling to remain competitive and this tax makes their effort to grow, innovate and invest in the future that much harder,” said Stephen J. Ubl, President and CEO of AdvaMed.
Leaders of New York’s bioscience and medical technology industry joined U.S. Rep. Bill Owens (D-NY) today to address how companies within the sector can drive the state’s economic competitiveness and future growth.
“Legislative measures to repeal the device tax passed the House last summer and the Senate in March with overwhelming bipartisan majorities. Congress and the President must act now to finish the job and repeal it.”
“Patient safety is the number one priority of the medical technology industry, and manufacturers have in place numerous safeguards to ensure the security and integrity of their devices..."
"CMS is a critical agency, and it needs a permanent administrator to lead it during this time of major change. Her deep experience in health care and her record of respectfully working with all the major stakeholders make her an excellent choice to lead CMS..."